Jul 26, 2022
23:20
For every 20 shares held, investors received 23.
The split itself did not change the total investment value.
CH Biotech R&D Co., Ltd. (TWSE:6534) operates in the Chemicals: agricultural industry.
CH Biotech R&D Co., Ltd. company overviewCH Biotech R&D Co., Ltd.'s most recent stock split was on July 26, 2022. It was a 23-for-20 forward split, so shareholders received 23 shares for every 20 they held.
CH Biotech R&D Co., Ltd. (TWSE:6534) has split its stock 3 times: a 67-for-50 split on July 2, 2019, a 21-for-20 split on July 23, 2020, and a 23-for-20 split on July 26, 2022.
CH Biotech R&D Co., Ltd. has split its stock 3 times. This history records 3 forward splits between July 2, 2019 and July 26, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In CH Biotech R&D Co., Ltd.'s 23-for-20 split on July 26, 2022, every 20 shares became 23 shares.
CH Biotech R&D Co., Ltd. has not announced a new split in our records. Its most recent split was on July 26, 2022, 4 years ago. Companies announce splits in advance, and any new TWSE:6534 split will appear on this page.
Already premium?